ZA949302B - Prolyl endopeptidase inhibitors. - Google Patents
Prolyl endopeptidase inhibitors.Info
- Publication number
- ZA949302B ZA949302B ZA949302A ZA949302A ZA949302B ZA 949302 B ZA949302 B ZA 949302B ZA 949302 A ZA949302 A ZA 949302A ZA 949302 A ZA949302 A ZA 949302A ZA 949302 B ZA949302 B ZA 949302B
- Authority
- ZA
- South Africa
- Prior art keywords
- prolyl endopeptidase
- endopeptidase inhibitors
- compounds
- formula
- present
- Prior art date
Links
- 239000003649 prolyl endopeptidase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 abstract 1
- 101710178372 Prolyl endopeptidase Proteins 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000006993 memory improvement Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16110693A | 1993-12-02 | 1993-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA949302B true ZA949302B (en) | 1995-08-07 |
Family
ID=22579844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA949302A ZA949302B (en) | 1993-12-02 | 1994-11-23 | Prolyl endopeptidase inhibitors. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5661167A (enExample) |
| EP (1) | EP0731788B1 (enExample) |
| JP (1) | JPH09506090A (enExample) |
| KR (1) | KR100341982B1 (enExample) |
| CN (1) | CN1136806A (enExample) |
| AT (1) | ATE223894T1 (enExample) |
| AU (1) | AU684861B2 (enExample) |
| CA (1) | CA2177821C (enExample) |
| DE (1) | DE69431359T2 (enExample) |
| DK (1) | DK0731788T3 (enExample) |
| ES (1) | ES2179093T3 (enExample) |
| HU (1) | HUT74687A (enExample) |
| IL (1) | IL111775A (enExample) |
| NO (1) | NO962238L (enExample) |
| NZ (1) | NZ276600A (enExample) |
| PT (1) | PT731788E (enExample) |
| TW (1) | TW280818B (enExample) |
| WO (1) | WO1995015310A1 (enExample) |
| ZA (1) | ZA949302B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| WO2006058720A2 (en) | 2003-11-03 | 2006-06-08 | Probiodrug Ag | Novel compounds for the treatment of neurological disorders |
| AU2004290499C1 (en) | 2003-11-03 | 2011-02-24 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| WO2005075436A2 (en) | 2004-02-05 | 2005-08-18 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| WO2008144748A1 (en) * | 2007-05-21 | 2008-11-27 | The Uab Research Foundation | Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| WO2015116590A1 (en) | 2014-01-28 | 2015-08-06 | Spirit Global Energy Solutions, Inc. | Down-hole gas and solids separator utilized in production hydrocarbons |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
| ZA86746B (en) * | 1985-02-04 | 1986-09-24 | Merrell Dow Pharma | Novel peptidase inhibitors |
| DE3712365A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
| US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
| JPH0662591B2 (ja) * | 1988-12-14 | 1994-08-17 | 株式会社ヤクルト本社 | 新規なチオプロリン誘導体 |
| US5118811A (en) * | 1989-04-13 | 1992-06-02 | Japan Tobacco Inc. | Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities |
-
1994
- 1994-11-08 AU AU10917/95A patent/AU684861B2/en not_active Ceased
- 1994-11-08 ES ES95901820T patent/ES2179093T3/es not_active Expired - Lifetime
- 1994-11-08 KR KR1019960702894A patent/KR100341982B1/ko not_active Expired - Fee Related
- 1994-11-08 CA CA002177821A patent/CA2177821C/en not_active Expired - Fee Related
- 1994-11-08 PT PT95901820T patent/PT731788E/pt unknown
- 1994-11-08 HU HU9601472A patent/HUT74687A/hu unknown
- 1994-11-08 WO PCT/US1994/012865 patent/WO1995015310A1/en not_active Ceased
- 1994-11-08 DE DE69431359T patent/DE69431359T2/de not_active Expired - Fee Related
- 1994-11-08 JP JP7515618A patent/JPH09506090A/ja not_active Ceased
- 1994-11-08 AT AT95901820T patent/ATE223894T1/de not_active IP Right Cessation
- 1994-11-08 CN CN94194374A patent/CN1136806A/zh active Pending
- 1994-11-08 NZ NZ276600A patent/NZ276600A/en unknown
- 1994-11-08 EP EP95901820A patent/EP0731788B1/en not_active Expired - Lifetime
- 1994-11-08 DK DK95901820T patent/DK0731788T3/da active
- 1994-11-23 ZA ZA949302A patent/ZA949302B/xx unknown
- 1994-11-24 TW TW083110932A patent/TW280818B/zh active
- 1994-11-27 IL IL111775A patent/IL111775A/en not_active IP Right Cessation
-
1996
- 1996-05-31 NO NO962238A patent/NO962238L/no not_active Application Discontinuation
- 1996-12-02 US US08/759,323 patent/US5661167A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL111775A (en) | 1998-06-15 |
| EP0731788B1 (en) | 2002-09-11 |
| ATE223894T1 (de) | 2002-09-15 |
| EP0731788A1 (en) | 1996-09-18 |
| CA2177821C (en) | 2000-03-28 |
| DK0731788T3 (da) | 2003-01-20 |
| DE69431359T2 (de) | 2003-07-31 |
| AU1091795A (en) | 1995-06-19 |
| IL111775A0 (en) | 1995-01-24 |
| WO1995015310A1 (en) | 1995-06-08 |
| US5661167A (en) | 1997-08-26 |
| NZ276600A (en) | 1997-09-22 |
| KR100341982B1 (ko) | 2002-11-30 |
| NO962238D0 (no) | 1996-05-31 |
| HU9601472D0 (en) | 1996-07-29 |
| CA2177821A1 (en) | 1995-06-08 |
| ES2179093T3 (es) | 2003-01-16 |
| CN1136806A (zh) | 1996-11-27 |
| JPH09506090A (ja) | 1997-06-17 |
| TW280818B (enExample) | 1996-07-11 |
| AU684861B2 (en) | 1998-01-08 |
| DE69431359D1 (de) | 2002-10-17 |
| NO962238L (no) | 1996-05-31 |
| HUT74687A (en) | 1997-01-28 |
| PT731788E (pt) | 2003-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW280818B (enExample) | ||
| ATE172968T1 (de) | Substituierte azadioxacycloalkene und ihre verwendung als fungizide | |
| MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
| TW263499B (enExample) | ||
| BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| MX9604367A (es) | Hidroxipiridinonas novedosas. | |
| CA2278694A1 (en) | Sulfamide-metalloprotease inhibitors | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| BR9408244A (pt) | Derivados de azabiciclo[3.2.0]heptano N-substituídos | |
| CA2032303A1 (en) | Inhibitors of retroviral proteases | |
| GR3029590T3 (en) | Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| PL322969A1 (en) | Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them | |
| UA39136C2 (uk) | Фармацевтична композиція, яка має активність, що зменшує патологічну гіперактивність еозинофільних гранулоцитів, та похідні ксантину | |
| PL312966A1 (en) | Derivatives of thiocarbamoil | |
| NO952926L (no) | Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer | |
| GR3029453T3 (en) | NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS | |
| MX9603722A (es) | Nuevos pseudopeptidos sustituidos con heterociclos. | |
| MX9706968A (es) | Compuesto de tiocarbamoilo. | |
| PL346003A1 (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
| MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. |